# ClinicalTrials.gov record NCT04943068

> PeptideScanner retained ClinicalTrials.gov record NCT04943068 at 2026-07-30T18:38:25.522Z. Its registry update date was 2024-11-13, and PeptideScanner's reviewed identity mapping was bremelanotide.

- Evidence object: `story:clinicaltrials-gov-nct04943068-bremelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-11-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04943068-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04943068-bremelanotide-v1.json
- Content SHA-256: `d391ea98acd30d9c524f7b243bdca39b6ec1ccfc99eedcce0adacd620263586f`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT04943068 ([`ctg-observation-nct04943068-2024-11-13-a4b75fe3baf4`](#source-ctg-observation-nct04943068-2024-11-13-a4b75fe3baf4))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04943068 at 2026-07-30T18:38:25.522Z. Its registry update date was 2024-11-13, and PeptideScanner's reviewed identity mapping was bremelanotide. ([`ctg-observation-nct04943068-2024-11-13-a4b75fe3baf4`](#source-ctg-observation-nct04943068-2024-11-13-a4b75fe3baf4))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04943068 at 2026-07-30T18:38:25.522Z. Its registry update date was 2024-11-13, and PeptideScanner's reviewed identity mapping was bremelanotide. ([`ctg-observation-nct04943068-2024-11-13-a4b75fe3baf4`](#source-ctg-observation-nct04943068-2024-11-13-a4b75fe3baf4))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04943068-2024-11-13-a4b75fe3baf4`](#source-ctg-observation-nct04943068-2024-11-13-a4b75fe3baf4))

## Sources

<a id="source-ctg-observation-nct04943068-2024-11-13-a4b75fe3baf4"></a>
- **ClinicalTrials.gov record NCT04943068 · retained source version 2024-11-13:a4b75fe3baf43e9306bfabc43d55ca8aca5455dbb3a0628eb40893874c0d6a48** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04943068) (`ctg-observation-nct04943068-2024-11-13-a4b75fe3baf4`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04943068." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04943068-bremelanotide-v1.json SHA-256: d391ea98acd30d9c524f7b243bdca39b6ec1ccfc99eedcce0adacd620263586f.